Our final survey of the life-science industry workplace highlights the companies—small and large, domestic and international—that are making their researchers feel valued and at home.
Our final survey of the life-science industry workplace highlights the companies—small and large, domestic and international—that are making their researchers feel valued and at home.
Scientists working in developing countries find that giving back to local communities enriches their own research.
Researcher salaries continue to buck the trend of the millennium’s first decade, remaining flat or even declining across most life science disciplines.
Epigenetic changes accrued over an organism’s lifetime may leave a permanent heritable mark on the genome, through the help of long noncoding RNAs.
Presenting the best life science images and videos of 2012
On the 10th anniversary of The Scientist’s survey of life science academics, institutions are contending with tighter budgets and larger administrative staffs, while working to sustain and inspire their researchers.
Much has changed in the 10 years since our first survey of industry researchers. Large companies are now looking to small, nimble ones for services as well as innovation.
After 20 years of high-profile failure, gene therapy is finally well on its way to clinical approval.
Targeting the briefest moment in chemistry may lead to an exceptionally strong new class of drugs.
Over the past 15 years, new laws and regulations in the United States and the European Union have expanded to require the inclusion of pediatric patients in clinical drug trials. Before these laws were enacted, the US Food and Drug Administration (F